Daniel F Ortwine Selected Research

Daniel F Ortwine Research Topics

6	Neoplasms (Cancer) 10/2016 - 08/2006
5	Asthma (Bronchial Asthma) 12/2016 - 12/2013
3	Pain (Aches) 01/2023 - 01/2018
2	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2021
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 06/2017
2	Arthritis (Polyarthritis) 01/2018 - 09/2007
2	Rheumatoid Arthritis 01/2018 - 06/2017
2	Osteoarthritis 02/2008 - 09/2007
1	autosomal dominant Spastic paraplegia 6 01/2019
1	Chronic Pain 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2017
1	Neuroblastoma 09/2013
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2010
1	Carcinoma (Carcinomatosis) 10/2007

4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2015 - 12/2013
3	emt protein-tyrosine kinase (IL2-inducible T-cell kinase)IBA 12/2016 - 07/2014
2	SulfonamidesIBA 01/2019 - 01/2018
2	Agammaglobulinaemia Tyrosine KinaseIBA 06/2017 - 10/2016
2	Interleukin-2 (IL2)IBA 05/2015 - 07/2014
2	Phosphotransferases (Kinase)IBA 07/2014 - 08/2006
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2014 - 12/2013
2	ZincIBA 09/2013 - 09/2007
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	SodiumIBA 01/2023
1	Estrogen ReceptorsIBA 10/2021
1	giredestrantIBA 01/2021
1	Estrogen Receptor AntagonistsIBA 01/2021
1	LigandsIBA 01/2019
1	fenebrutinibIBA 01/2018
1	Sodium Channels (Sodium Channel)IBA 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2016
1	ibrutinibIBA 10/2016
1	Tyrosine (L-Tyrosine)FDA Link 07/2014
1	Histones (Histone)IBA 09/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 09/2013
1	BenzamidesIBA 09/2013
1	Histone Deacetylase InhibitorsIBA 09/2013
1	Hydroxamic Acids (Hydroxamic Acid)IBA 09/2013
1	GDC-0349IBA 01/2013
1	Protein Kinases (Protein Kinase)IBA 01/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2012
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2012
1	HhAntag691IBA 04/2011
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2010
1	Matrix Metalloproteinase 13IBA 02/2008
1	QuinazolinonesIBA 02/2008
1	EnzymesIBA 10/2007
1	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA 10/2007
1	Matrix Metalloproteinase InhibitorsIBA 09/2007
1	Peptide Hydrolases (Proteases)FDA Link 09/2007

2	Therapeutics 01/2018 - 09/2013
1	Drug Therapy (Chemotherapy) 08/2006